Financial reports
NT 10-K
Notice of late annual filing
1 Apr 14
10-Q
2013 Q3
Quarterly report
4 Dec 13
NT 10-Q
Notice of late quarterly filing
15 Nov 13
10-Q
2013 Q2
Quarterly report
19 Aug 13
NT 10-Q
Notice of late quarterly filing
15 Aug 13
10-Q
2013 Q1
Quarterly report
9 May 13
10-K
2012 FY
Annual report
12 Apr 13
NT 10-K
Notice of late annual filing
2 Apr 13
10-Q
2012 Q3
Quarterly report
15 Nov 12
NT 10-Q
Notice of late quarterly filing
15 Nov 12
Current reports
8-K
Departure of Directors or Certain Officers
27 Mar 15
8-K
Vansen Pharma Completes Acquisition of Consumer Health Products Entities
18 Mar 14
8-K
Vansen Pharma Inc. Appoints New President and Ceo
3 Mar 14
8-K
Entry into a Material Definitive Agreement
21 Jan 14
8-K/A
Entry into a Material Definitive Agreement
29 Nov 13
8-K
Changes in Registrant's Certifying Accountant
28 Oct 13
8-K
Amendments to Articles of Incorporation or Bylaws
30 Aug 13
8-K
Entry into a Material Definitive Agreement
8 Aug 13
8-K
Changes in Registrant's Certifying Accountant
22 Feb 13
8-K
Changes in Registrant's Certifying Accountant
20 Aug 12
Proxies
No filings